Mansour, Nabeel; Heinrich, Kathrin; Zhang, Danmei; Winkelmann, Michael; Ingenerf, Maria; Gold, Lukas; Klambauer, Konstantin; Rudelius, Martina; Klauschen, Frederick; Bergwelt-Baildon, Michael von; Ricke, Jens; Heinemann, Volker; Westphalen, C. Benedikt; Kunz, Wolfgang G. (2024): Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation. Cancer Imaging, 24 (1). ISSN 1470-7330

Ingenerf, Maria; Rübenthaler, Johannes; Wenter, Vera; Zacherl, Mathias; Völter, Friederike; Winkelmann, Michael; Karim, Homeira; Schinner, Regina; Ricke, Jens; Berger, Frank; Schmid-Tannwald, Christine (2023): Evaluation of MRI in the diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors in comparison with the reference standard somatostatin-receptor–PET/CT. Frontiers in Oncology, 13: 1194152. ISSN 2234-943X

Mönch, Sebastian; Heimer, Maurice M.; Winkelmann, Michael; Guertler, Anne; Schlaak, Max; Tufman, Amanda; Ben Khaled, Najib; de Toni, Enrico; Westphalen, Christoph B.; von Bergwelt-Baildon, Michael; Dinkel, Julien; Kazmierczak, Philipp M.; Ingrisch, Michael; Mansour, Nabeel; Unterrainer, Marcus; Heinzerling, Lucie; Ricke, Jens; Kunz, Wolfgang G. (2023): Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors. Cancer Imaging, 23 (1). ISSN 1470-7330

Winkelmann, Michael; Blumenberg, Viktoria; Rejeski, Kai; Bücklein, Veit L.; Ingenerf, Maria; Unterrainer, Marcus; Schmidt, Christian; Dekorsy, Franziska J.; Bartenstein, Peter; Ricke, Jens; von Bergwelt-Baildon, Michael; Subklewe, Marion; Kunz, Wolfgang G. (2023): Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria. Cancer Imaging, 23 (1). ISSN 1470-7330

Winkelmann, Michael; Bücklein, Veit L.; Blumenberg, Viktoria; Rejeski, Kai; Ruzicka, Michael; Unterrainer, Marcus; Schmidt, Christian; Dekorsy, Franziska J.; Bartenstein, Peter; Ricke, Jens; von Bergwelt-Baildon, Michael; Subklewe, Marion; Kunz, Wolfgang G. (2022): Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment. Frontiers in Oncology, 12. ISSN 2234-943X